William W. Ericson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Mateo, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Brett Atkins, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for William W. Ericson

Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
MDV ENF VII (A), L.P.
Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
MDV ENF VII (B), L.P.
Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
MDV VII Leaders' Fund, L.P.
Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
MDV VII, L.P.
Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Form 4 holding Director, 10%+ Owner

Adamas Pharmaceuticals Inc

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by William W. Ericson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .